高级检索
王思亮, 陈晓东, 吴荣, 钱昊初. 多西他赛联合FOLFOX方案治疗进展期胃癌临床疗效观察[J]. 实用临床医药杂志, 2011, (9): 59-61. DOI: 10.3969/j.issn.1672-2353.2011.09.019
引用本文: 王思亮, 陈晓东, 吴荣, 钱昊初. 多西他赛联合FOLFOX方案治疗进展期胃癌临床疗效观察[J]. 实用临床医药杂志, 2011, (9): 59-61. DOI: 10.3969/j.issn.1672-2353.2011.09.019
shu
WANG Si-liang, CHEN Xiao-dong, WU Rong, QIAN Hao-chu. Clinical observation of Docetaxel combined with FOLFOX on advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2011, (9): 59-61. DOI: 10.3969/j.issn.1672-2353.2011.09.019
Citation: WANG Si-liang, CHEN Xiao-dong, WU Rong, QIAN Hao-chu. Clinical observation of Docetaxel combined with FOLFOX on advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2011, (9): 59-61. DOI: 10.3969/j.issn.1672-2353.2011.09.019
shu

多西他赛联合FOLFOX方案治疗进展期胃癌临床疗效观察

Clinical observation of Docetaxel combined with FOLFOX on advanced gastric cancer

    摘要
  • 摘要: 目的 观察多西他赛联合FOLFOX方案治疗进展期胃癌的疗效及不良反应.方法 对32例进展期胃癌行多西他赛联合FOLFOX方案化疗,3周为1周期,完成2个周期后评价疗效.结果 化疗总有效率37.5%,中位疾病进展时间6.3个月,中位生存期10.4个月.不良反应以骨髓抑制、胃肠道反应和静脉炎为主.结论 多西他赛联合FOLFOX方案治疗进展期胃癌有较好的疗效,毒副作用可以耐受,可作为进展期胃癌一线治疗方案.

     

    • HTML全文
    • 参考文献(11)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回